Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $7.24, but opened at $7.89. Aspen Pharmacare shares last traded at $7.89, with a volume of 552 shares.
Aspen Pharmacare Price Performance
The company has a quick ratio of 1.18, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The company has a 50 day moving average price of $6.68 and a two-hundred day moving average price of $6.08.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
See Also
- Five stocks we like better than Aspen Pharmacare
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
